David R. Nalin - Concepedia

Author

David R. Nalin

Also Known As

D R Nalin, D. Nalin, D. R. NALIN, D. R. Nalin, D.R. Nalin, DAVID NALIN, DAVID R. NALIN, David Nalin, David R Nalin, David R. Nalin

107

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

United States Military Academy University of Maryland, Baltimore Centers for Disease Control and Prevention Hadassah Academic College National Institute of Allergy and Infectious Diseases

About

David R. Nalin is an author at United States Military Academy specializing in medicine, vaccination, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	29	1.4K
2	Health Sciences	4	4	115
3	Public Health	4	4	151
4	Engineering	1	1	159
5	Allergy	1	1	53

David R. Nalin

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
A Controlled Trial of a Formalin-Inactivated Hepatitis A Vaccine in Healthy Children Alan Werzberger, Barbara Mensch, Barbara J. Kuter, New England Journal of Medicine	1992	539
Duration of Infection-Derived Immunity to Cholera M. M. Levine, Robert E. Black, M L Clements, The Journal of Infectious Diseases	1981	253
Ivermectin for Human Strongyloidiasis and other Intestinal Helminths César Náquira, Gerardo Jimenez, Jorge Guerra, American Journal of Tropical Medicine and Hygiene	1989	183
Immunity to Enterotoxigenic <i>Escherichia coli</i> Myron M. Levine, David R. Nalin, David L. Hoover, Infection and Immunity	1979	180
Immunity of cholera in man: Relative role of antibacterial versus antitoxic immunity Myron M. Levine, David R. Nalin, John P. Craig, Transactions of the Royal Society of Tropical Medicine and Hygiene Relative RoleExperimental ChallengeMicrobial DiseaseAntibioticsTyphoid Fever	1979	179
Adsorption and growth of Vibrio cholerae on chitin David R. Nalin, V. Daya, Alison J. Reid, Infection and Immunity Chitin ParticlesEngineeringMedicinePathogenesisVibrio Cholerae	1979	159
The Pathogenicity of Nonenterotoxigenic Vibrio cholerae Serogroup 01 Biotype EI Tor Isolated from Sewage Water in Brazil Myron M. Levine, Robert E. Black, M L Clements, The Journal of Infectious Diseases	1982	101
Evaluation of Influenza A/Hong Kong/123/77 (H1N1) <i>ts</i> -1A2 and Cold-Adapted Recombinant Viruses in Seronegative Adult Volunteers Brian R. Murphy, Margret B. Rennels, R. Gordon Douglas, Infection and Immunity	1980	99
Duration of protection from clinical hepatitis A disease after vaccination with VAQTA® Brian L. Wiens, Norman R. Bohidar, Joseph G. Pigeon, Journal of Medical Virology VaccinationVaccine SafetyAntibody DecayExpected PersistenceViral Hepatitis	1996	93
A Clinical Trial of Oral Therapy in a Rural Cholera-Treatment Center Richard A. Cash, David R. Nalin, Roger Rochat, American Journal of Tropical Medicine and Hygiene	1970	92

Page 1